Professor John Ormiston was honoured for his pioneering role in interventional cardiology.

The annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) and the world-leading PCR course in interventional cardiology held in Paris, France honoured Professor John Ormiston as this year's recipient of the  annual Ethica Award.  

This is Europe’s most prestigious award in interventional cardiology. Each year the course directors bestow the Ethica Award on remarkable individuals who have significantly contributed to the field of cardiovascular intervention as teachers, innovators, scientists, care providers, or pioneers. The is the first time the Ethica Award has been awarded in the Southern Hemsiphere.

The award acknowledges Prof. Ormiston’s role in pioneering catheter based cardiac intervention  specifically his work investigating important innovations such as stents,  bioresorbable stents, and transcatheter aortic valve implantation (TAVI). 

Prof. Ormiston has been involved with absorbable scaffolds from an early stage, and became the principal investigator of the ABSORB trial. In particular, Prof. Ormiston pioneered the use of scanning electron microscopy and micro CT to demonstrate different stent deployments with various technologies and strategies in bifurcations to determine their strengths and weaknesses and the best ways to deploy them.